The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Postischemic Blockade of AMPA but Not NMDA Receptors Mitigates Neuronal Damage in the Rat Brain following Transient Severe Cerebral Ischemia
Abstract
Glutamatergic transmission is an important factor in the development of neuronal death following transient cerebral ischemia. In this investigation the effects of N-methyl-d-aspartate (NMDA) and non-NMDA receptor antagonists on neuronal damage were studied in rats exposed to 10 min of transient cerebral ischemia induced by bilateral common carotid occlusion combined with hypotension. The animals were treated with a blocker of the ionotropic quisqualate or α-amino-3-hydroxy-5-methyl-4-isoxazole (AMPA) receptor, 2.3-dihydroxy-6-nitro-7-sulfamoyl-benzo( F)quinoxaline (NBQX), given postischemia as an intraperitoneal bolus dose of 30 mg kg−1 followed by an intravenous infusion of 75 μg min−1 for 6 h, or with the noncompetitive NMDA receptor blocker dizocilpine(MK-801) given 1 mg kg−1 i.p. at recirculation and 3 h postischemia, or with the competitive NMDA receptor antagonist dl-( E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CGP 40116), 5 mg kg−1, given intraperitoneally at recirculation. Treatment with NBQX provided a significant reduction of neuronal damage in the hippocampal CA 1 area by 44–69%, with the largest relative decrease in the temporal part of the hippocampus. In neocortex a significant decrease in the number of necrotic neurons was also noted. No protection could be seen following postischemic treatment with dizocilpine or CGP 40116. Our data demonstrate that AMPA but not NMDA receptor antagonists decrease neuronal damage following transient severe cerebral ischemia in the rat and that the protection by NBQX may be dependent on the severity of the ischemic insult. We propose that the AMPA receptor–mediated neurotoxicity could be due to ischemia-induced changes in the control mechanisms of AMPA receptor–coupled processes or to changes of AMPA receptor characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,491
Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Cell Damage in the Brain: A Speculative Synthesis
Siesjö, B. K. (1981) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1981.18 · Cited by 1,815
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage
Choi, D. W. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90200-7 · Cited by 1,736
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682
A Family of AMPA-Selective Glutamate Receptors
Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990) · Science · doi:10.1126/science.2166337 · Cited by 1,479
Ca2 + Permeability of KA-AMPA—Gated Glutamate Receptor Channels Depends on Subunit Composition
Hollmann, M., Hartley, M., & Heinemann, S. (1991) · Science · doi:10.1126/science.1709304 · Cited by 1,456
Flip and Flop: A Cell-Specific Functional Switch in Glutamate-Operated Channels of the CNS
Sommer, B., Keinänen, K., Verdoorn, T. A., Wisden, W., Burnashev, N., Herb, A., Kohler, M., Takagi, T., Sakmann, B., & Seeburg, P. H. (1990) · Science · doi:10.1126/science.1699275 · Cited by 1,259
Siesjö, B. K., & Bengtsson, F. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.20 · Cited by 1,231
Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists
Honoré, T., Davies, S. N., Drejer, J., Fletcher, E. J., Jacobsen, P., Lodge, D., & Nielsen, F. E. (1988) · Science · doi:10.1126/science.2899909 · Cited by 1,191
Cited by
Ischemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
Pathophysiology and treatment of focal cerebral ischemia: Part I: Pathophysiology
Siesjö, B. K. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0169 · Cited by 1,295
Brain ischemia and reperfusion: molecular mechanisms of neuronal injury
White, B. C., Sullivan, J. M., DeGracia, D. J., O’Neil, B. J., Neumar, R. W., Grossman, L. I., Rafols, J. A., & Krause, G. S. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00386-5 · Cited by 796
Siesjö, B. K. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.3.0337 · Cited by 657
Excitotoxicity and the NMDA receptor -- still lethal after eight years
Rothman, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93869-y · Cited by 508
Dietrich, W. D., Busto, R., Alonso, O., Globus, M. Y.-T., & Ginsberg, M. D. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.71 · Cited by 470
Donevan, S. D., & Rogawski, M. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90241-i · Cited by 358
The problem of assessing effective neuroprotection in experimental cerebral ischemia
Corbett, D. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00078-6 · Cited by 278
Ischemic tolerance in the brain
Chen, J., & Simon, R. (1997) · Neurology · doi:10.1212/wnl.48.2.306 · Cited by 271
Bai, J., & Lyden, P. D. (2015) · International Journal of Stroke · doi:10.1111/ijs.12434 · Cited by 270
Postischemic hypothermia: A critical appraisal with implications for clinical treatment
Colbourne, F., Sutherland, G., & Corbett, D. (1997) · Molecular Neurobiology · doi:10.1007/bf02740655 · Cited by 269
Novel Pharmacologic Therapies in the Treatment of Experimental Traumatic Brain Injury: A Review
McINTOSH, T. K. (1993) · Journal of Neurotrauma · doi:10.1089/neu.1993.10.215 · Cited by 266
Deshpande, J., Bergstedt, K., Lindén, T., Kalimo, H., & Wieloch, T. (1992) · Experimental Brain Research · doi:10.1007/bf02259131 · Cited by 262
Self-citationNeuroprotective effects of the green tea components theanine and catechins
Kakuda, T. (2002) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.25.1513 · Cited by 165
Astrocytic contributions to bioenergetics of cerebral ischemia
Dienel, G. A., & Hertz, L. (2005) · Glia · doi:10.1002/glia.20157 · Cited by 150
KAKUDA, T., NOZAWA, A., SUGIMOTO, A., & NIINO, H. (2002) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.66.2683 · Cited by 131
Protective effect of γ-glutamylethylamide (theanine) on ischemic delayed neuronal death in gerbils
Kakuda, T., Yanase, H., Utsunomiya, K., Nozawa, A., Unno, T., & Kataoka, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01286-6 · Cited by 91
Ikegaya, Y., Kim, J.-A., Baba, M., Iwatsubo, T., Nishiyama, N., & Matsuki, N. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.22.4083 · Cited by 88
Brain damage in a mouse model of global cerebral ischemia
Olsson, T., Wieloch, T., & Smith, M.-L. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03014-2 · Cited by 87
Self-citationGao, T.-M., Pulsinelli, W. A., & Xu, Z. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00150-x · Cited by 43
Zukhurova, M., Prosvirnina, M., Daineko, A., Simanenkova, A., Petrishchev, N., Sonin, D., Galagudza, M., Shamtsyan, M., Juneja, L. R., & Vlasov, T. (2013) · Phytotherapy Research · doi:10.1002/ptr.4868 · Cited by 42
Metadata
- Authors
- Nellgård, B., & Wieloch, T.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 1992-01
- Volume
- 12
- Issue
- 1
- Pages
- 2-11
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2071961923
- Cited by
- 314
- References
- 50
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.